Xanthine Oxidase Inhibition With Febuxostat Attenuates Systolic Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice
- 30 November 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Cardiac Failure
- Vol. 14 (9), 746-753
- https://doi.org/10.1016/j.cardfail.2008.06.006
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Extracellular superoxide dismutase protects the heart against oxidative stress and hypertrophy after myocardial infarctionFree Radical Biology & Medicine, 2008
- Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: Effects of early versus delayed treatmentLife Sciences, 2008
- Extracellular Superoxide Dismutase Deficiency Exacerbates Pressure Overload–Induced Left Ventricular Hypertrophy and DysfunctionHypertension, 2008
- Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload–Induced Ventricular Hypertrophy and Congestive Heart FailureCirculation Research, 2007
- Acute Effects of Febuxostat, a Nonpurine Selective Inhibitor of Xanthine Oxidase, in Pacing Induced Heart FailureJournal of Cardiovascular Pharmacology, 2006
- Xanthine Oxidoreductase Inhibition Causes Reverse Remodeling in Rats With Dilated CardiomyopathyCirculation Research, 2006
- Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse heartsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failureJournal of Molecular and Cellular Cardiology, 2005
- Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenaseLife Sciences, 2005
- Rapamycin Attenuates Load-Induced Cardiac Hypertrophy in MiceCirculation, 2003